Another prescription-strength Zantac recall for, maybe, having too much of a carcinogen

All unexpired lots of 150mg and 300mg ranitidine (over-the-counter brand name: Zantac) tablets distributed by by Glenmark Pharmaceutical were recalled late Tuesday for possibly having too much NDMA. Patients are … Click to Continue »

View original article
Contributor: